Returns Chart

Key Stats

Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
1.51% 615.23M -- 108.2%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
49.89M 4.99%

Basic Info

Investment Strategy
The Fund invests primarily in long and short positions of equity securities of companies anywhere in the world. The Fund may use leverage through the use of short selling of up to 50% of its net asset value and by investing in derivatives.The Fund's gross exposure is calculated as the sum of the following, and must not exceed 300% of its net asset value: (i) the aggregate market value of securities sold short; (ii) the value of indebtedness under any borrowing arrangements for investment purposes; and (iii) the aggregate notional value of the Fund's specified derivatives positions excluding any specified derivatives used for hedging purposes.
General
Security Type Mutual Fund
Equity Style --
Broad Asset Class Alternative
Broad Category Alternative Strategies
Global Peer Group Alternative Long/Short Equity Global
Peer Group Alternative Equity Focused
Global Macro Alternative Equity
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Fidelity Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: 9
-49.84M Peer Group Low
331.93M Peer Group High
1 Year
% Rank: 24
49.89M
-420.59M Peer Group Low
3.406B Peer Group High
3 Months
% Rank: 12
-80.35M Peer Group Low
1.131B Peer Group High
3 Years
% Rank: 87
-1.085B Peer Group Low
9.354B Peer Group High
6 Months
% Rank: 22
-149.41M Peer Group Low
2.005B Peer Group High
5 Years
% Rank: 12
-1.565B Peer Group Low
10.18B Peer Group High
YTD
% Rank: 11
-80.35M Peer Group Low
835.47M Peer Group High
10 Years
% Rank: 12
-310.83M Peer Group Low
10.53B Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
1.44%
68.06%
-28.02%
-16.50%
8.49%
10.36%
21.93%
5.56%
28.04%
-6.24%
12.05%
21.04%
29.06%
4.08%
--
4.93%
35.33%
-5.26%
7.35%
16.17%
15.52%
8.50%
--
25.41%
9.87%
-18.29%
17.56%
36.31%
14.69%
-2.12%
--
--
--
-16.78%
38.19%
32.98%
9.56%
-10.75%
As of April 06, 2026.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (4-2-26) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 127
Stock
Weighted Average PE Ratio 21.65
Weighted Average Price to Sales Ratio 3.845
Weighted Average Price to Book Ratio 4.255
Weighted Median ROE 13.23%
Weighted Median ROA 3.81%
ROI (TTM) 5.79%
Return on Investment (TTM) 5.79%
Earning Yield 0.0625
LT Debt / Shareholders Equity 1.051
Number of Equity Holdings 112
As of January 31, 2026

Growth Metrics

EPS Growth (1Y) 14.01%
EPS Growth (3Y) -3.63%
EPS Growth (5Y) 4.00%
Sales Growth (1Y) 5.48%
Sales Growth (3Y) 5.55%
Sales Growth (5Y) 8.46%
Sales per Share Growth (1Y) 9.81%
Sales per Share Growth (3Y) 5.81%
Operating Cash Flow - Growth Rate (3Y) 2.69%
As of January 31, 2026

Asset Allocation

As of January 31, 2026.
Type % Net
Cash 30.93%
Stock 67.28%
Bond 0.78%
Convertible 0.00%
Preferred 0.00%
Other 1.01%
View Asset Allocation
Start Trial

Top 10 Holdings

Name % Weight Price % Change
USD Cash
25.89% -- --
Fidelity U.S. Money Market Investment Trust Sr O
10.35% -- --
British American Tobacco plc 4.50% 60.90 6.16%
Imperial Brands Plc 4.21% 42.08 3.59%
Metro, Inc. 3.57% 96.88 0.46%
Diageo Plc 3.53% 18.89 1.49%
Target Corp. 3.51% 122.21 1.46%
Pernod Ricard SA 3.19% 71.32 -2.01%
Pfizer Inc. 3.10% 27.88 -1.55%
Cidara Therapeutics Inc ORD
3.03% -- --

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee --
Administration Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for RRSP Yes
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 5000.00 None
Minimum Subsequent Investment 25.00 None

Basic Info

Investment Strategy
The Fund invests primarily in long and short positions of equity securities of companies anywhere in the world. The Fund may use leverage through the use of short selling of up to 50% of its net asset value and by investing in derivatives.The Fund's gross exposure is calculated as the sum of the following, and must not exceed 300% of its net asset value: (i) the aggregate market value of securities sold short; (ii) the value of indebtedness under any borrowing arrangements for investment purposes; and (iii) the aggregate notional value of the Fund's specified derivatives positions excluding any specified derivatives used for hedging purposes.
General
Security Type Mutual Fund
Equity Style --
Broad Asset Class Alternative
Broad Category Alternative Strategies
Global Peer Group Alternative Long/Short Equity Global
Peer Group Alternative Equity Focused
Global Macro Alternative Equity
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Fidelity Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (4-2-26) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 127
Stock
Weighted Average PE Ratio 21.65
Weighted Average Price to Sales Ratio 3.845
Weighted Average Price to Book Ratio 4.255
Weighted Median ROE 13.23%
Weighted Median ROA 3.81%
ROI (TTM) 5.79%
Return on Investment (TTM) 5.79%
Earning Yield 0.0625
LT Debt / Shareholders Equity 1.051
Number of Equity Holdings 112
As of January 31, 2026

Growth Metrics

EPS Growth (1Y) 14.01%
EPS Growth (3Y) -3.63%
EPS Growth (5Y) 4.00%
Sales Growth (1Y) 5.48%
Sales Growth (3Y) 5.55%
Sales Growth (5Y) 8.46%
Sales per Share Growth (1Y) 9.81%
Sales per Share Growth (3Y) 5.81%
Operating Cash Flow - Growth Rate (3Y) 2.69%
As of January 31, 2026

Fund Details

Key Dates
Launch Date 10/16/2020
Share Classes
FID2146 Commission-based Advice
FID2147 Commission-based Advice
FID2148 Commission-based Advice
FID2149 Fee-based Advice
FID2153 Fee-based Advice
FID7132 Commission-based Advice
FID7133 Commission-based Advice
FID7134 Commission-based Advice
FID7135 Fee-based Advice
FID7136 Fee-based Advice
FID7137 Fee-based Advice
Attributes
Inverse Fund No
Leveraged Fund --
Currency Hedged Fund Yes
Socially Responsible Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial

Excel Add-In Codes

Name: =YCI("M:FID2151.TO", "name")
Broad Asset Class: =YCI("M:FID2151.TO", "broad_asset_class")
Broad Category: =YCI("M:FID2151.TO", "broad_category_group")
Prospectus Objective: =YCI("M:FID2151.TO", "prospectus_objective")
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.
View Excel Add-In Codes
Start Trial